Oncology Division
Alphabetical list (active faculty):   
Julie O'Neal

Julie O'Neal, PhD

Assistant Professor

Department of Medicine

Oncology Division

Stem Cell Biology

Research Interests

  • CAR-T therapy for multiple myeloma
  • Novel therapeutics for multiple myeloma
  • Genomics and biology of multiple myeloma


  • 314-273-4524 (office)
  • 314-273-4525 (lab)
  • 314-362-9333 (fax)
  • Division of Oncology
    Mail Stop 8007-0021-09
    Washington University
    660 South Euclid Avenue
    St. Louis, MO 63110
  • Room 9933, Wohl Clinic Building (office)


Although outcomes for multiple myeloma have improved, most patients die from relapsed disease. My research focus is to further our understanding of the biology of multiple myeloma so we can use new information to better identify, design, and test novel therapies that will improve outcomes of myeloma patients. Chimeric Antigen Receptor (CAR) proteins are hybrid proteins expressed on T cells (CAR-T) that kill cells expressing a specific target protein on their surface. We are using preclinical myeloma models to test efficacy of tumor cells (CAR-T) with the goal to generate a CAR product that will be used to effectively cure myeloma patients. In addition to a panel of targets already being tested, we are using expression and proteomic analysis to identify novel myeloma CAR targets. We are also exploring other immune cell types that may prove useful for expressing CAR proteins and killing tumor cells.